1.Coronary Flow Reserve: An Index for Viability?.
Korean Circulation Journal 1998;28(2):157-160
No abstract available.
2.Safety and Clinical Impact of Ergonovine Stress Echocardiography for Diagnosis of Coronary Vasospasm.
Jae Kwan SONG ; Seong Wook PARK ; Duk Hyun KANG
Korean Circulation Journal 2000;30(8):937-946
BACKGROUND: The safety of ergonovine provocation for coronary vasospasm (CVS) performed outside the catheterization laboratory has been questioned. We sought to address the issues of safety, feasibility and clinical impact of noninvasive diagnosis of CVS. METHOD AND RESULTS: We retrospectively analyzed the results of bedside ergonovine provocation testing with monitoring of left ventricular regional wall motion abnormalities (RWMAs) by 2-dimensional echocardiography (ergonovine echocardiography, Erg Echo). After confirmation of no significant fixed epicardial coronary artery disease, 1,504 Erg Echo were performed in 1,372 patients from July 1991 to December 1997. Erg Echo was prematurely terminated in 13 patients (0.9%) due to limiting side effects unrelated with myocardial ischemia. Among 1,491 completed tests, 32% (477) showed positive results with development of RWMAs in 467 tests (98%) or ST displacement in ECG in 10 tests (2%). During the test, transient arrhythmias developed in 1.7% (26/1491) including transient ventricular tachycardia (2) and atrioventricular block (4), which were promptly reversed with nitroglycerin. There were no procedure-related death or development of myocardial infarction. On the basis of angiographic criteria in 218 patients, who also underwent invasive spasm provocation test during coronary angiography, the sensitivity and specificity of Erg Echo for the diagnosis of CVS were 93% and 91% respectively. From 1990 to 1997, total 2,073 spasm provocation tests were performed either during invasive coronary angiography in the catheterization or in the echocardiography laboratory. Since 1994, noninvasive Erg Echo became a more popular diagnostic method and comprised more than 95% of all spasm provocation tests in recent 3 years. Erg Echo was also performed safely in outpatient clinic setting without hospital admission in 34% (500/1491). CONCLUSIONS: Erg Echo is highly feasible, accurate and safe for diagnosis of CVS and can replace the invasive spasm provocation test during coronary angiography in the catheterization laboratory.
Ambulatory Care Facilities
;
Arrhythmias, Cardiac
;
Atrioventricular Block
;
Catheterization
;
Catheters
;
Coronary Angiography
;
Coronary Artery Disease
;
Coronary Vasospasm*
;
Diagnosis*
;
Echocardiography
;
Echocardiography, Stress*
;
Electrocardiography
;
Ergonovine*
;
Humans
;
Myocardial Infarction
;
Myocardial Ischemia
;
Nitroglycerin
;
Retrospective Studies
;
Sensitivity and Specificity
;
Spasm
;
Tachycardia, Ventricular
3.Safety and Clinical Impact of Ergonovine Stress Echocardiography for Diagnosis of Coronary Vasospasm.
Jae Kwan SONG ; Seong Wook PARK ; Duk Hyun KANG
Korean Circulation Journal 2000;30(8):937-946
BACKGROUND: The safety of ergonovine provocation for coronary vasospasm (CVS) performed outside the catheterization laboratory has been questioned. We sought to address the issues of safety, feasibility and clinical impact of noninvasive diagnosis of CVS. METHOD AND RESULTS: We retrospectively analyzed the results of bedside ergonovine provocation testing with monitoring of left ventricular regional wall motion abnormalities (RWMAs) by 2-dimensional echocardiography (ergonovine echocardiography, Erg Echo). After confirmation of no significant fixed epicardial coronary artery disease, 1,504 Erg Echo were performed in 1,372 patients from July 1991 to December 1997. Erg Echo was prematurely terminated in 13 patients (0.9%) due to limiting side effects unrelated with myocardial ischemia. Among 1,491 completed tests, 32% (477) showed positive results with development of RWMAs in 467 tests (98%) or ST displacement in ECG in 10 tests (2%). During the test, transient arrhythmias developed in 1.7% (26/1491) including transient ventricular tachycardia (2) and atrioventricular block (4), which were promptly reversed with nitroglycerin. There were no procedure-related death or development of myocardial infarction. On the basis of angiographic criteria in 218 patients, who also underwent invasive spasm provocation test during coronary angiography, the sensitivity and specificity of Erg Echo for the diagnosis of CVS were 93% and 91% respectively. From 1990 to 1997, total 2,073 spasm provocation tests were performed either during invasive coronary angiography in the catheterization or in the echocardiography laboratory. Since 1994, noninvasive Erg Echo became a more popular diagnostic method and comprised more than 95% of all spasm provocation tests in recent 3 years. Erg Echo was also performed safely in outpatient clinic setting without hospital admission in 34% (500/1491). CONCLUSIONS: Erg Echo is highly feasible, accurate and safe for diagnosis of CVS and can replace the invasive spasm provocation test during coronary angiography in the catheterization laboratory.
Ambulatory Care Facilities
;
Arrhythmias, Cardiac
;
Atrioventricular Block
;
Catheterization
;
Catheters
;
Coronary Angiography
;
Coronary Artery Disease
;
Coronary Vasospasm*
;
Diagnosis*
;
Echocardiography
;
Echocardiography, Stress*
;
Electrocardiography
;
Ergonovine*
;
Humans
;
Myocardial Infarction
;
Myocardial Ischemia
;
Nitroglycerin
;
Retrospective Studies
;
Sensitivity and Specificity
;
Spasm
;
Tachycardia, Ventricular
4.Coronary Artery Stenting(Palmaz-Schatz) ; Immediate Results.
Seung Jung PARK ; Seong Wook PARK ; Jae Joong KIM ; Jae Kwan SONG ; Simon Jong LEE
Korean Circulation Journal 1991;21(5):809-820
Since after first report of percutaneous transluminal coronary angioplasty in 1977, improved operator technique and advanced equipment designs have resulted in an increase in primary success rate from 67% to 92% in recent days. Despite these improvement, acute closure and restenosis remain as serious limitations to both the short and long-term success of PTCA. Coronary artery stents have been proposed as a method of treating acute closure and preventing restenosis. We implanted 21 balloon expandable Palmaz-Schatz Stent in selected 21 Patients(mean age 62+/-8 years, M/F : 16/5) with atherosclerotic coronary artery disease. The indications were elective stenting in 17, acute dissection postangioplasty in 2 and restenosis following angioplasty in 2. The clinical diagnosis of the subjects was unstable angina in 12 pts(57%), stable angina in 1, and post infarction angina in 8 including 6 acute myocardial infarction. The target vessel was right coronary artery In 12(57%), left anterior descending artery in 6(29%) and left circumflex in 3(14%). The size of implanted stent was 3mm in 15, 3.5mm in 5 and 4.0mm in 1. The morphology of attempted lesion was AHA/ACC classification type A in 1, type B in 17(B1 ; 1, B2 ; 16) and type C in 3. Angiographic findings were 1-vessel disease in 16 patients, 2-vessel disease in 4 and 3-vessel disease in 1. Coronary artery stenting wast technically successful in 21 all patients(100%) and complications included subacute total occlusion 1 week after stenting in 1, which was recanalized successfully by repeat PTCA without myocardial infarction, prolonged sinus arrest after stenting due to microembolism in 1 and puncture site bleeding requiring transfusion in 1. CONCLUSION: Coronary artery stenting was a safe and effective procedure to obtain adequate coronary blood flow in selected patients but long-term efficacy of primary elective coronary stenting should be evaluated prospectively.
Angina, Stable
;
Angina, Unstable
;
Angioplasty
;
Angioplasty, Balloon, Coronary
;
Arteries
;
Classification
;
Coronary Artery Disease
;
Coronary Vessels*
;
Diagnosis
;
Equipment Design
;
Hemorrhage
;
Humans
;
Infarction
;
Myocardial Infarction
;
Punctures
;
Stents
5.Coronary Artery Stenting(Palmaz-Schatz) ; Immediate Results.
Seung Jung PARK ; Seong Wook PARK ; Jae Joong KIM ; Jae Kwan SONG ; Simon Jong LEE
Korean Circulation Journal 1991;21(5):809-820
Since after first report of percutaneous transluminal coronary angioplasty in 1977, improved operator technique and advanced equipment designs have resulted in an increase in primary success rate from 67% to 92% in recent days. Despite these improvement, acute closure and restenosis remain as serious limitations to both the short and long-term success of PTCA. Coronary artery stents have been proposed as a method of treating acute closure and preventing restenosis. We implanted 21 balloon expandable Palmaz-Schatz Stent in selected 21 Patients(mean age 62+/-8 years, M/F : 16/5) with atherosclerotic coronary artery disease. The indications were elective stenting in 17, acute dissection postangioplasty in 2 and restenosis following angioplasty in 2. The clinical diagnosis of the subjects was unstable angina in 12 pts(57%), stable angina in 1, and post infarction angina in 8 including 6 acute myocardial infarction. The target vessel was right coronary artery In 12(57%), left anterior descending artery in 6(29%) and left circumflex in 3(14%). The size of implanted stent was 3mm in 15, 3.5mm in 5 and 4.0mm in 1. The morphology of attempted lesion was AHA/ACC classification type A in 1, type B in 17(B1 ; 1, B2 ; 16) and type C in 3. Angiographic findings were 1-vessel disease in 16 patients, 2-vessel disease in 4 and 3-vessel disease in 1. Coronary artery stenting wast technically successful in 21 all patients(100%) and complications included subacute total occlusion 1 week after stenting in 1, which was recanalized successfully by repeat PTCA without myocardial infarction, prolonged sinus arrest after stenting due to microembolism in 1 and puncture site bleeding requiring transfusion in 1. CONCLUSION: Coronary artery stenting was a safe and effective procedure to obtain adequate coronary blood flow in selected patients but long-term efficacy of primary elective coronary stenting should be evaluated prospectively.
Angina, Stable
;
Angina, Unstable
;
Angioplasty
;
Angioplasty, Balloon, Coronary
;
Arteries
;
Classification
;
Coronary Artery Disease
;
Coronary Vessels*
;
Diagnosis
;
Equipment Design
;
Hemorrhage
;
Humans
;
Infarction
;
Myocardial Infarction
;
Punctures
;
Stents
6.Manidipine Monotherapy in Patients with Mild to Moderate Essential Hypertension.
Jong Koo LEE ; Seong Wook PARK ; Jae Kwan SONG ; Jae Joong KIM ; Seung Jung PARK
Korean Circulation Journal 1992;22(2):301-306
A clinical trial was done to evaluate the antihypertensive efficacy and side effects of manidipine, a new calcium antagonist, in 30 patients with mild to moderate essential hypertension. 1) The study patients consisted of 19 men and 11 women, and the mean age was 51.8 years. 2) Blood pressure dropped significantly in 2 weeks and in 4 weeks, and well maintained throughout the study period. The mean-pressure drop was 26.2/14.9mmHg after 10 weeks. 3) Heart rate did not change significantly with manidipine therpy. 4) Optimal dose for effective pressure-drop was between 10 and 20 mg in 86% of patients. Overall good antihypertensive effect was achieved in 83% of patients. 5) All of the laboratory parameters including blood chemistry, glucose, lipid and electrolytes did not change, but serum calcium increased from 9.2% mg/dl (p=0.001) in 10 weeks. 6) Side effects were mild in nature(palpitation in 3, dry mouth in 1, weakness in 1 and impotence in 1 patient). In conclusion, manidipine monotherapy with 10 to 20 mg once a day regimen is effective and well tolerated in the patients with mild to moderate essential hypertension.
Blood Pressure
;
Calcium
;
Chemistry
;
Electrolytes
;
Erectile Dysfunction
;
Female
;
Glucose
;
Heart Rate
;
Humans
;
Hypertension*
;
Male
;
Mouth
7.Production of monoclona antibody to infectious bursal disease virus as a diagnostic methods.
Hyung Kwan JANG ; Jai Hong KIM ; Chang Seon SONG ; Soon Jae KIM ; Tae Jong KIM
Journal of the Korean Society of Virology 1993;23(2):171-182
No abstract available.
Infectious bursal disease virus*
8.Ergonovine Echocardiography for the Diagnosis of Vasospastic Angina.
Journal of Cardiovascular Ultrasound 2006;14(1):7-11
No abstract available.
Diagnosis*
;
Echocardiography*
;
Ergonovine*
9.Assessment of the Accuracy of Digitally Recorded Velocity Information of Color Doppler Flow Mapping:in vitro Validation Using a Flow Phantom.
Jae Kwan SONG ; Duk Hyun KANG ; Mark D HANDSCHUMACHER ; Robert A LEVINE
Korean Circulation Journal 1999;29(4):429-439
BACKGROUND: Qunatitation of blood flow within the cardiac chambers has been tried using digitally recorded velocity information of color Doppler flow mapping (CDFM). However, the accuracy of CDFM has not been systematically assessed. The purpose of the study was to test the accuracy of digitally recorded velocity information obtained through CDFM. Method: Using the American Society of Echocardiography flow phantom, an in vitro steady flow experiment was performed. Eight different flow fields through the phantom (84, 139, 172, 192, 232, 237, 244, 436 mL/sec) were imaged by CDFM using Hewlett Packard Sonos 2500 and all data were stored in the magneto-optical disc. Multiple aliases were visible and 7 different Nyquist limits (17, 23, 27, 37, 42, 53, 58 cm/sec) were used for recording. A fully automatic computer algorithm was used to unwrap the aliases and to convert the CDFM to digital velocity. Among 9 consecutive values at each pixel along the centerline of the phantom, median value was chosen as a representative value, which was compared to the actual value. RESULTS: In the slow velocity region, CDFM tends to overestimate the true velocity, whereas in the fast velocity region, it underestimates. At the aliasing point of 2 times Nyquist limit, there is a marked turbulence and estimation of velocity is impossible;fter aliasing, velocity information of CDFM is totally unreliable. Velocity estimation of CDFM is the most accurate at the velocity region of the Nyquist limit and shows reasonable accuracy between 0.5 x Nyquist limit and 1.5 x Nyquist limit with the error of estimation less than 15%. Conclusion: Velocity information of CDFM is accurate in the limited region and is dependent on the Nyquist limit of each measurement;this can be explained by the effect of wall filter. Baseline-shift of CDFM should be limited to the region between 0.5 x Nyquist limit and 1.5 x Nyquist limit for accurate quantitation using velocity information of CDFM.
Echocardiography
10.Infective endocarditis involving an apparently structurally normal valve: new epidemiological trend?.
The Korean Journal of Internal Medicine 2015;30(4):434-442
Infective endocarditis (IE) has been increasingly diagnosed in patients without previously detected predisposing heart disease, but its clinical features have yet to be fully determined. A recent single-center study including echocardiographic images and surgical findings investigated the incidence of undiagnosed, clinically silent valvular or congenital heart diseases and healthcare-associated infective endocarditis (HAIE). The study confirmed that a large proportion of patients with IE have no previous history of heart disease. Analysis of underlying disease in these patients showed that undetected mitral valve prolapse was the most common disease, followed by an apparently structurally normal valve. The patients who developed IE of apparently structurally normal valves had different clinical characteristics and worse outcomes. IE involving a structurally normal valve was associated with both nosocomial and non-nosocomial HAIE, whereas community-acquired IE was more frequent than HAIE. The pathophysiologic mechanism involving the development of non-HAIE or community-acquired IE due to predominantly staphylococcal infection in an apparently structurally normal valve is not yet clearly understood. Structurally normal valves are not necessarily free of regurgitation or abnormal turbulence and, given the dynamic nature and fluctuating hemodynamic effects of conditions such as poorly controlled hypertension, end-stage renal disease, and sleep apnea, further investigation is necessary to evaluate the potential role of these diseases in the development of IE. An apparently normal-looking valve is associated with IE development in patients without previously recognized predisposing heart disease, warranting repartition of at-risk groups to achieve better clinical outcomes.
Adult
;
Aged
;
Community-Acquired Infections/diagnosis/*epidemiology/microbiology/physiopathology/therapy
;
Cross Infection/diagnosis/*epidemiology/microbiology/physiopathology/therapy
;
Echocardiography, Doppler, Color
;
Endocarditis, Bacterial/diagnosis/*epidemiology/microbiology/physiopathology/therapy
;
Female
;
Heart Valves/*microbiology/physiopathology/ultrasonography
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Predictive Value of Tests
;
Prognosis
;
Risk Factors